I agree that this site is using cookies. You can find further informations here.
X
the NIAID HIV Vaccine Trials Network
38  results:
Search for persons X
?
1

Safety, pharmacokinetics, and immunological activities of m..:

Mayer, Kenneth H. ; Seaton, Kelly E. ; Huang, Yunda...
PLOS Medicine.  14 (2017)  11 - p. e1002435 , 2017
Link: https://doi.org/10.1371/..
 
?
2

A New Model for Catalyzing Translational Science: The Early..:

Adamson, Blythe J.S. ; Fuchs, Jonathan D. ; Sopher, Carrie J....
Clinical and Translational Science.  8 (2014)  2 - p. 166-168 , 2014
Link: https://doi.org/10.1111/..
 
?
3

Safety and Comparative Immunogenicity of an HIV-1 DNA Vacci..:

Kalams, Spyros A. ; Parker, Scott D. ; Elizaga, Marnie...
The Journal of Infectious Diseases.  208 (2013)  5 - p. 818-829 , 2013
Link: https://doi.org/10.1093/..
 
?
4

Exploring Barriers and Facilitators to Participation of Mal..:

HVTN 505 study team ; Andrasik, Michele Peake ; Yoon, Ro...
Prevention Science.  15 (2013)  3 - p. 268-276 , 2013
Link: https://doi.org/10.1007/..
 
?
5

Using an internet consumer marketing strategy to reach men ..:

The NIAID HIV Vaccine Trials Network ; Voytek, CD ; Jones, KT...
Retrovirology.  9 (2012)  S2 - p. , 2012
Link: https://doi.org/10.1186/..
 
?
6

Vaccination with MVA/HIV induces differential recruitment o..:

the NIAID HIV Vaccine Trials Network ; Andersen-Nissen, E ; Zak, DE...
Retrovirology.  9 (2012)  S2 - p. , 2012
Link: https://doi.org/10.1186/..
 
?
7

Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with ..:

Kalams, Spyros A. ; Parker, Scott ; Jin, Xia...
PLoS ONE.  7 (2012)  1 - p. e29231 , 2012
Link: https://doi.org/10.1371/..
 
?
8

A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1..:

Churchyard, Gavin J. ; Morgan, Cecilia ; Adams, Elizabeth...
PLoS ONE.  6 (2011)  8 - p. e21225 , 2011
Link: https://doi.org/10.1371/..
 
?
9

Safety and Immunogenicity of an HIV Adenoviral Vector Boost..:

Koblin, Beryl A. ; Casapia, Martin ; Morgan, Cecilia...
PLoS ONE.  6 (2011)  9 - p. e24517 , 2011
Link: https://doi.org/10.1371/..
 
?
10

Safety and Immunogenicity of a Replication-Defective Adenov..:

Peiperl, Laurence ; Morgan, Cecilia ; Moodie, Zoe...
PLoS ONE.  5 (2010)  10 - p. e13579 , 2010
Link: https://doi.org/10.1371/..
 
?
11

High‐Dose Recombinant Canarypox Vaccine Expressing HIV‐1 Pr..:

Goepfert, Paul A. ; Horton, Helen ; McElrath, M. Juliana...
The Journal of Infectious Diseases.  192 (2005)  7 - p. 1249-1259 , 2005
Link: https://doi.org/10.1086/..
 
?
12

Meta-analysis of HIV-1 vaccine elicited mucosal antibodies ..:

Seaton, Kelly E. ; Deal, Aaron ; Han, Xue...
npj Vaccines.  6 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
13

Timing of Plasmid Cytokine (IL-2/Ig) Administration Affects..:

Baden, Lindsey R. ; Blattner, William A. ; Morgan, Cecilia...
The Journal of Infectious Diseases.  204 (2011)  10 - p. 1541-1549 , 2011
Link: https://doi.org/10.1093/..
 
?
14

Testing the waters: Ethical considerations for including Pr..:

Dawson, Liza ; Garner, Sam ; Anude, Chuka...
Clinical Trials.  12 (2015)  4 - p. 394-402 , 2015
Link: https://doi.org/10.1177/..
 
?
15

P15-13. HVTN 503(Phambili) trial discontinuation of enrolme..:

t NIAID HIV Vaccine Trials Network ; Mark, D ; Middelkoop, K...
Retrovirology.  6 (2009)  S3 - p. , 2009
Link: https://doi.org/10.1186/..
 
1-15